The treatment of gout in the acute phase is different from that in the remission phase. When gout is in acute attack, the pain caused by inflammation needs to be controlled as soon as possible to relieve the patient’s pain, which requires the use of non-steroidal anti-inflammatory drugs or colchicine to control the symptoms, and the use of uric acid-lowering drugs such as allopurinol and benzbromarone in small doses to reduce the uric acid level only when the symptoms are relieved. If the use of large amounts of uric acid-lowering drugs during the acute phase of gout lowers uric acid too quickly, it will lead to the re-dissolution of uric acid crystals deposited in the synovial membrane of the joint ligaments too quickly, leading to an inflammatory reaction that will aggravate joint pain. Therefore, the treatment of gout needs to be taken according to the stage and medical prescription.